Stock News

Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments
Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO
FDA Rebukes Amgen Over Misleading Branding Of Neulasta
Amgen And The International Federation of Psoriasis Associations Launch UPLIFT Innovation Challenge
BeiGene-Amgen's Kyprolis Gets Approval In China For Pre-Treated Multiple Myeloma Patients
Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA
UPDATE 1-AstraZeneca-Amgen drug gets FDA speedy review as asthma treatment
Tezepelumab Granted Priority Review By U.S. FDA
Here's Why Biohaven Pharmaceutical Is Soaring Today
Amgen Pumps $365M Into New Ohio Facility

As seen on...